Biovaxys Technology Corp Stock Market Value
| BVAXF Stock | USD 0.04 0.01 17.99% |
| Symbol | Biovaxys |
Biovaxys Technology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biovaxys Technology's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biovaxys Technology.
| 01/02/2025 |
| 02/01/2025 |
If you would invest 0.00 in Biovaxys Technology on January 2, 2025 and sell it all today you would earn a total of 0.00 from holding Biovaxys Technology Corp or generate 0.0% return on investment in Biovaxys Technology over 30 days. Biovaxys Technology is related to or competes with Covalon Technologies, Mosaic Immunoengineerin, Cellectis, and GH Research. BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms More
Biovaxys Technology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biovaxys Technology's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biovaxys Technology Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 37.17 | |||
| Value At Risk | (12.41) | |||
| Potential Upside | 10.4 |
Biovaxys Technology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biovaxys Technology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biovaxys Technology's standard deviation. In reality, there are many statistical measures that can use Biovaxys Technology historical prices to predict the future Biovaxys Technology's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | 1.09 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biovaxys Technology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biovaxys Technology Corp Backtested Returns
Biovaxys Technology Corp secures Sharpe Ratio (or Efficiency) of -0.0481, which signifies that the company had a -0.0481 % return per unit of risk over the last 3 months. Biovaxys Technology Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biovaxys Technology's Standard Deviation of 6.54, risk adjusted performance of (0.03), and Mean Deviation of 4.54 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.3, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Biovaxys Technology are expected to decrease at a much lower rate. During the bear market, Biovaxys Technology is likely to outperform the market. At this point, Biovaxys Technology Corp has a negative expected return of -0.33%. Please make sure to confirm Biovaxys Technology's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Biovaxys Technology Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.16 |
Insignificant reverse predictability
Biovaxys Technology Corp has insignificant reverse predictability. Overlapping area represents the amount of predictability between Biovaxys Technology time series from 2nd of January 2025 to 17th of January 2025 and 17th of January 2025 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biovaxys Technology Corp price movement. The serial correlation of -0.16 indicates that over 16.0% of current Biovaxys Technology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.16 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biovaxys Technology Corp lagged returns against current returns
Autocorrelation, which is Biovaxys Technology otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biovaxys Technology's otc stock expected returns. We can calculate the autocorrelation of Biovaxys Technology returns to help us make a trade decision. For example, suppose you find that Biovaxys Technology has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biovaxys Technology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biovaxys Technology otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biovaxys Technology otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biovaxys Technology otc stock over time.
Current vs Lagged Prices |
| Timeline |
Biovaxys Technology Lagged Returns
When evaluating Biovaxys Technology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biovaxys Technology otc stock have on its future price. Biovaxys Technology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biovaxys Technology autocorrelation shows the relationship between Biovaxys Technology otc stock current value and its past values and can show if there is a momentum factor associated with investing in Biovaxys Technology Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Biovaxys OTC Stock
Biovaxys Technology financial ratios help investors to determine whether Biovaxys OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovaxys with respect to the benefits of owning Biovaxys Technology security.